Will unprecedented movements of Alvogen bear fruit?
The American generic-centered pharmaceutical company, Alvogen, is about to finish its 3-year expansion project to the Korean market, and started to move towards the new goal to become the top 5 in the Asia-Pacific region.
The industry has paid attention to the new start of Alvogen which will sho...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
